🇺🇸 FDA

Intelligence · Patent portfolio

Teva Pharma Patents

Full USPTO pharma patent portfolio for Teva Pharma — grant dates, expiration, and drug cross-links.

Patents
454
Expiring ≤24m
49

Quick answer

Teva Pharma has 454 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 49 expire within 24 months — use filters for patent-cliff planning.

Page 6 of 10

  1. US 7777034

    Crystalline ammonium salts of rosuvastatin

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7772219

    Methods of hormonal treatment utilizing extended cycle contraceptive regimens

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7759500

    2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7750051

    Crystalline solid rasagiline base

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7749536

    Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7741482

    Reference standard for characterization of rosuvastatin

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7737177

    Processes for preparing crystalline and amorphous mupirocin calcium

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7692008

    Reference standard for characterization of rosuvastatin

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7692009

    Reference standard for characterization of rosuvastatin

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7692010

    Reference standard for characterization of rosuvastatin

    Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7687660

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7687642

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7687622

    Process for preparing quetiapine fumarate

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7683188

    Process for preparation of mycophenolic acid and ester derivatives thereof

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7683080

    Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7683177

    Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7678799

    Crystalline ziprasidone HCl and processes for preparation thereof

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7678938

    Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7678816

    Method of stabilizing lansoprazole

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7674480

    Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7674935

    Crystal forms of O-desmethylvenlafaxine

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7671071

    Polymorphic Form XVI of fexofenadine hydrochloride

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7645876

    Processes for producing crystalline macrolides

    Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7632841

    2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

    Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7629458

    Preparation of levofloxacin and hemihydrate thereof

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7622588

    Method for the purification of lansoprazole

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7618976

    Methods for the production of sildenafil base and citrate salt

    Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7619112

    Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

    Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7619117

    Rasagiline formulations and processes for their preparation

    Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7611722

    Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

    Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7612203

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7608714

    Production of dolasetron

    Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7605274

    Carvedilol

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7605290

    Processes for the synthesis of O-desmethylvenlafaxine

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7598420

    Rasagiline formulations and processes for their preparation

    Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7598396

    Crystalline solids of carvedilol and processes for their preparation

    Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7589100

    Non-hygroscopic and powdery amorphous pimecrolimus

    Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7582759

    Diastereomeric purification of rosuvastatin

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7579333

    Therapy using a combination of raloxifene and alendronate

    Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7572834

    Rasagiline formulations and processes for their preparation

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7572641

    Pharmaceutical compositions comprising meloxicam and methods of their preparation

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7569729

    Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7563918

    Solid and crystalline ibandronate sodium and processes for preparation thereof

    Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7563930

    Crystal forms of Cinacalcet HCI and processes for their preparation

    Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7547787

    Processes for preparing montelukast sodium

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7547806

    Tannate salt of rasagiline

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7538136

    Crystalline forms of atorvastatin

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Teva Pharma have?

454 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

49 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.